Synthesis of methylphenidate and analogs thereof
View Patent ↗A synthetic process for the preparation of amino acid esters such as methylphenidate and analogs thereof is disclosed. The process involves reacting an amino acid such as α-phenyl-α-(2-piperidinyl)acetic acid or an analog thereof with an alcohol such as methanol in the presence of an acid and a water sequestrant such as trimethyl orthoacetate. In some embodiments, the water sequestrant is added to the reaction mixture after an initial period of esterification and then the reaction is allowed to continue. The α-phenyl-α-(2-piperidinyl)acetic acid methyl ester or analog thereof is then isolated from the reaction mixture. In one variation of the process, the supernatant liquid may be recycled in subsequent runs to increase yield and product purity.
1. A synthetic esterification process comprising:
(i) reacting
(a) an amino acid of Formula I:
wherein R a is a substituent at one or more of carbons 2, 3, 4, 5 and 6 of the phenyl ring, wherein the substituent is independently selected from the group consisting of hydrogen, alkyl, alkoxy, haloalkyl, haloalkoxy, hydroxyalkyl, alkoxyalkyl, halogen and —NR m R n , wherein R m and R n are independently selected from the group consisting of hydrogen, alkyl, haloalkyl and alkoxyalkyl;
wherein R b is a substituent at one or more of carbons 7, 8, 9, 10 and 11 of the piperidine ring, wherein the substituent is independently selected from the group consisting of hydrogen, oxo, alkyl, alkoxy, haloalkyl, haloalkoxy, hydroxyalkyl, alkoxyalkyl and halogen; and
wherein R c is selected from the group consisting of hydrogen, alkyl, haloalkyl, aralkyl, cycloalkylalkyl, hydroxyalkyl, alkoxyalkyl, and
wherein R t is selected from the group consisting of alkyl, alkoxy, cycloalkyl, cycloalkylalkyl, aralalkoxy and aralkyl;
with
(b) an alcohol of formula R y —OH, wherein R y is selected from the group consisting of alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, and heteroaralkyl;
in the presence of
(c) an acid;
and
(d) a water sequestrant
to produce a reaction mixture containing an amino acid ester of Formula II
and
(ii) isolating the amino acid ester of Formula II or a pharmaceutically acceptable salt thereof.
2. The process of claim 1 , wherein the amino acid is ritalinic acid.
3. The process of claim 1 , wherein the water sequestrant is an orthoester of the formula R x C(OR y ) 3 , wherein R x is hydrogen or alkyl and R y is as previously defined; and the acid is selected from the group consisting of methanesulfonic acid, p-toluenesulfonic acid, hydrochloric acid, hydrobromic acid, sulfuric acid, and phosphoric acid.
4. The process of claim 1 , wherein the water sequestrant is CH 3 C(OCH 3 ) 3 .
5. The process of claim 1 , wherein the water sequestrant is employed in an amount from about 0.5 to about 4 molar equivalents to that of the amino acid; the alcohol is employed in an amount from about 5 to about 50 molar equivalents to that of the amino acid of Formula I; and the acid is employed in an amount from about 0.5 to about 4 molar equivalents to that of the amino acid of Formula I.
6. The process of claim 1 , wherein the alcohol is methanol.
7. The process of claim 1 , wherein the reaction is carried out from about 25° C. to about 150° C.
8. The process of claim 1 , wherein the water sequestrant is added to the reaction mixture prior to complete conversion to the amino acid ester of Formula II.
9. The process of claim 1 , wherein isolating comprises precipitating or crystallizing the amino acid ester of Formula II or a pharmaceutically acceptable salt thereof from the mixture.
10. The process of claim 9 , further comprising capturing supernatant remaining after precipitating or crystallizing the amino acid ester of Formula II or a pharmaceutically acceptable salt thereof; and repeating (i) through (ii) one or more times utilizing captured supernatant.
11. A process for preparing threo-α-phenyl-α-(2-piperidinyl)acetic acid methyl ester, the process comprising (i) reacting threo-α-phenyl-α-(2-piperidinyl)acetic acid with methanol in the presence of a water sequestrant and an acid; and (ii) isolating the threo-α-phenyl-α-(2-piperidinyl)acetic acid methyl ester or a pharmaceutically acceptable salt thereof.
12. The process of claim 11 , wherein the water sequestrant is an orthoester of formula R x C(OCH 3 ) 3 , wherein R x is hydrogen or alkyl.
13. The process of claim 11 , wherein the water sequestrant is CH 3 C(OCH 3 ) 3 .
14. The process of claim 11 , wherein the water sequestrant is employed in an amount from about 0.5 to about 4 molar equivalents to that of threo-α-phenyl-α-(2-piperidinyl)acetic acid; the methanol is employed in an amount from about 5 to about 50 molar equivalents to that of threo-α-phenyl-α-(2-piperidinyl)acetic acid; and the acid is employed in an amount from about 0.5 to about 4 molar equivalents to that of threo-α-phenyl-α-(2-piperidinyl)acetic acid.
15. The process of claim 11 , wherein the acid is selected from the group consisting of methanesulfonic acid, p-toluenesulfonic acid, hydrochloric acid, hydrobromic acid, sulfuric acid, and phosphoric acid.
16. The process of claim 11 , wherein the reaction is carried out from about 0° C. to about 200° C.
17. The process of claim 11 , wherein the reaction is carried out from about 25° C. to about 150° C.
18. The process of claim 11 , wherein the reaction is carried out from about 50° C. to about 100° C.
19. The process of claim 11 , wherein isolating threo-α-phenyl-α-(2-piperidinyl)acetic acid methyl ester or a pharmaceutically acceptable salt thereof is by precipitation or crystallization from the reaction mixture.
20. The process of claim 19 , further comprising capturing supernatant remaining after precipitation or crystallization of the threo-α-phenyl-α-(2-piperidinyl)acetic acid methyl ester or a pharmaceutically acceptable salt thereof; and repeating (i) through (ii) one or more times utilizing captured supernatant.